AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
12.02
-0.16 (-1.31%)
May 12, 2026, 11:17 AM EDT - Market open
AgomAb Therapeutics NV Market Cap
AgomAb Therapeutics NV has a market cap or net worth of $591.96 million as of May 12, 2026.
Market Cap
591.96M
Enterprise Value
470.42M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.02
Market Cap Chart
Since the IPO on February 6, 2026, AgomAb Therapeutics NV's market cap has decreased from $779.79M to $591.96M, a decrease of -24.09%. That is a compound annual growth rate of -65.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 599.84M | 0.41% |
| May 8, 2026 | 597.38M | 6.22% |
| May 7, 2026 | 562.41M | -6.70% |
| May 6, 2026 | 602.80M | -2.08% |
| May 5, 2026 | 615.60M | 3.26% |
| May 4, 2026 | 596.15M | 8.18% |
| May 1, 2026 | 551.08M | 3.13% |
| Apr 30, 2026 | 534.34M | 1.02% |
| Apr 29, 2026 | 528.92M | 0.94% |
| Apr 28, 2026 | 524.00M | -6.01% |
| Apr 27, 2026 | 557.49M | 2.44% |
| Apr 24, 2026 | 544.19M | 3.27% |
| Apr 23, 2026 | 526.95M | 2.49% |
| Apr 22, 2026 | 514.17M | -3.65% |
| Apr 21, 2026 | 533.67M | 1.48% |
| Apr 20, 2026 | 525.87M | -4.77% |
| Apr 17, 2026 | 552.19M | 1.16% |
| Apr 16, 2026 | 545.85M | 5.07% |
| Apr 15, 2026 | 519.53M | 1.81% |
| Apr 14, 2026 | 510.27M | 0.48% |
| Apr 13, 2026 | 507.84M | -1.14% |
| Apr 10, 2026 | 513.69M | 3.23% |
| Apr 9, 2026 | 497.60M | 3.65% |
| Apr 8, 2026 | 480.06M | -6.28% |
| Apr 7, 2026 | 512.22M | -10.17% |
| Apr 6, 2026 | 570.22M | 9.14% |
| Apr 2, 2026 | 522.46M | -9.00% |
| Apr 1, 2026 | 574.12M | 12.30% |
| Mar 31, 2026 | 511.25M | 6.39% |
| Mar 30, 2026 | 480.54M | -9.12% |
| Mar 27, 2026 | 528.79M | -8.59% |
| Mar 26, 2026 | 578.51M | -7.70% |
| Mar 25, 2026 | 626.75M | 10.43% |
| Mar 24, 2026 | 567.54M | -4.94% |
| Mar 23, 2026 | 597.03M | 0.49% |
| Mar 20, 2026 | 594.10M | -4.02% |
| Mar 19, 2026 | 618.96M | -8.30% |
| Mar 18, 2026 | 675.00M | 1.02% |
| Mar 17, 2026 | 668.18M | -4.23% |
| Mar 16, 2026 | 697.67M | 3.36% |
| Mar 13, 2026 | 675.00M | -0.43% |
| Mar 12, 2026 | 677.93M | 2.51% |
| Mar 11, 2026 | 661.36M | -1.31% |
| Mar 10, 2026 | 670.13M | -4.71% |
| Mar 9, 2026 | 703.27M | 5.95% |
| Mar 6, 2026 | 663.79M | -4.15% |
| Mar 5, 2026 | 692.55M | -3.20% |
| Mar 4, 2026 | 715.46M | -7.67% |
| Mar 3, 2026 | 774.91M | -1.91% |
| Mar 2, 2026 | 790.02M | 1.19% |
| Feb 27, 2026 | 780.76M | 0.06% |
| Feb 26, 2026 | 780.28M | -0.62% |
| Feb 25, 2026 | 785.15M | 0.75% |
| Feb 24, 2026 | 779.30M | 3.83% |
| Feb 23, 2026 | 750.55M | -0.65% |
| Feb 20, 2026 | 755.42M | -0.70% |
| Feb 19, 2026 | 760.78M | 6.19% |
| Feb 18, 2026 | 716.43M | -2.97% |
| Feb 17, 2026 | 738.36M | -1.24% |
| Feb 13, 2026 | 747.62M | -2.04% |
| Feb 12, 2026 | 763.22M | -2.13% |
| Feb 11, 2026 | 779.79M | 2.89% |
| Feb 10, 2026 | 757.86M | -0.38% |
| Feb 9, 2026 | 760.78M | -2.44% |
| Feb 6, 2026 | 779.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 631.46M |
| Kyverna Therapeutics | 625.88M |
| Arvinas | 623.24M |
| Cabaletta Bio | 622.85M |
| Crescent Biopharma | 615.40M |
| Valneva SE | 611.89M |
| CorMedix | 600.87M |
| Altimmune | 600.08M |